Literature summary for 3.4.15.1 extracted from

Bowen, M.E.; Ray, W.A.; Arbogast, P.G.; Ding, H.; Cooper, W.O.
Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy (2008), Am. J. Obstet. Gynecol., 198, 291.e1-291.e5.

Search for more literature for 3.4.15.1

Application

Application	Comment	Organism
medicine	despite evidence of fetal complications associated with angiotensin-converting enzyme inhibitor use during pregnancy, the number of pregnant women with pregnancy-related ACE inhibitor exposures increases steadily between 1986-2003. Better methods are needed to reduce fetal exposure to potentially teratogenic prescribed medications	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)